Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with ...

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...

Examples of selflessness are hard to find in today’s world.However, there are still some people in the world who think of ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

A year after guidelines were revised to remove the use of race in eGFR, many labs and pathologists were still relying on the ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Older adults with advanced kidney disease are often motivated to receive a transplant but may face emotional and psychosocial ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...

A race-based method for calculating kidney function resulted in many Black patients being lower on the transplant waitlist ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...